Open original FDA record ↗Recall record
- FDA identifier
- Z-1012-2012
- Company in FDA record
- Cytophil, Inc
- FDA classification date
- Feb 13, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Cytophil Corporation is recalling Periophil Biphasic Periophil Biphasic, Periobase Biphasic, and Periobone Biphasic because devices were inadvertently shipped after receiving an inadequate dose of radiation and this product may not be sterile.
Source facts
- Action
- Consignees were sent an "Urgent Medical Device Recall" letter dated January 11, 2012 by Cytophil. The letter described the problem and the product involved in the recall. The firm advised consignees to immediately examine their inventory and quarantine product subject to recall. In addition, if they have further distributed this product, they were requested to identify their customers and notify them at once of this product recall. For questions, call 262-642-2765.
- Initiated
- 2012-01-11
- Root cause
- Process control
- Terminated
- 2012-05-01
- Distribution
- Nationwide Distribution - Including the states of WI, GA, IL, SC, MO, and TX.
- Recall number
- Z-1012-2012
- Recall status
- Terminated
- CDRH record ID
- 107165
- FDA classified
- 2012-02-13
- Recall event number
- 61044